SCL.NYSEStepan CO

Form 4: Stepan EVP Haire Boosts Holdings with Stock, RSU Grants

Sentiment:

Insider Transaction Report


Stepan Company's EVP of Supply Chain, Robert Haire, reported significant acquisitions of common stock, restricted stock units, performance shares, and stock appreciation rights.

Better than expectedThe EVP acquired additional common stock, indicating confidence in the company.Significant equity grants (RSUs, Performance Shares, SARs) were made, aligning executive incentives with long-term company performance and shareholder value.

Summary

  • Robert Haire, EVP, Supply Chain, acquired 56.765 shares of Stepan Company common stock at $52.51 per share on February 27, 2026.
  • Haire was granted 5,993 Restricted Stock Units (RSUs) on March 2, 2026, which vest ratably over three years starting March 2, 2027, and represent a contingent right to receive one share of common stock per unit.
  • Haire received a grant of 2,996 Performance Shares on March 2, 2026, which vest upon the company achieving specific performance goals by December 31, 2028.
  • Haire was granted 8,586 Stock Appreciation Rights (SARs) on March 2, 2026, with an exercise price of $17.47, vesting ratably over three years starting March 2, 2027, and expiring on March 3, 2036.
  • Following these transactions, Haire directly owns 2,538.765 shares of common stock and indirectly owns 90.269 shares via the ESOP II Trust.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive signal, as an executive's acquisition of common stock and substantial equity grants demonstrate confidence in the company's future and align management incentives with shareholder interests.

Positives

  • Significant grants of equity-based compensation (RSUs, Performance Shares, SARs) align management's interests with shareholder value creation.
  • Direct acquisition of common stock by an executive demonstrates confidence in the company's future performance.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that equity grants to executives are a standard practice across industries, particularly in the chemicals sector, to incentivize long-term performance and align executive interests with shareholder returns. The specific mix of RSUs, performance shares, and SARs reflects a common strategy to balance retention with performance-based incentives.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of Attorney GrantRobert Haire granted a Power of Attorney to Shawn Lisle, Kamel Aranki, James Andrew Hart, and Darina Koleva to execute and file Forms 3, 4, and 5 on his behalf, ensuring timely compliance with Section 16 reporting requirements.01/12/2026Enhances efficiency and ensures compliance with SEC reporting obligations for insider transactions.

Stakeholder Impact

  • Shareholders: The grants of performance-based equity compensation align executive incentives with shareholder value creation, potentially leading to improved long-term performance. The direct stock purchase by an executive may signal confidence to other investors.

Next Steps

  • Vesting of Restricted Stock Units and Stock Appreciation Rights will occur ratably over three years, starting March 2, 2027.
  • Performance Shares will vest upon certification of Stepan Company achieving specific performance goals for the period ending December 31, 2028.

Key Dates

DateDescription
01/12/2026Date Power of Attorney was executed by Robert Haire.
02/27/2026Acquisition date for 56.765 shares of Common Stock.
03/02/2026Grant date for Restricted Stock Units, Performance Shares, and Stock Appreciation Rights.
03/02/2027Start of three-year ratable vesting period for Restricted Stock Units and Stock Appreciation Rights.
12/31/2028End of performance period for Performance Shares.
03/02/2029Expiration date for Restricted Stock Units.
03/03/2036Expiration date for Stock Appreciation Rights.

Recommendation

hold

The insider's acquisition of common stock and substantial equity grants are positive indicators of management confidence and alignment with shareholder interests. However, a Form 4 filing alone does not provide sufficient comprehensive financial data to warrant a 'buy' recommendation without further analysis of the company's broader financial health and market position. It reinforces a 'hold' position for existing investors and suggests a positive signal for potential investors to conduct further due diligence.

Keywords

Stepan Company, SCL, Insider Trading, Form 4, Robert Haire, EVP Supply Chain, Stock Grant, RSU, Performance Shares, SAR, Equity Compensation, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.